Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E26.68 EPS (ttm)1.42 Insider Own0.30% Shs Outstand1.47B Perf Week1.39%
Market Cap55.86B Forward P/E15.37 EPS next Y2.47 Insider Trans-0.91% Shs Float1.47B Perf Month-1.99%
Income2.13B PEG2.84 EPS next Q0.53 Inst Own70.80% Short Float3.65% Perf Quarter-6.70%
Sales20.39B P/S2.74 EPS this Y53.50% Inst Trans-0.31% Short Ratio5.56 Perf Half Y-14.90%
Book/sh14.03 P/B2.70 EPS next Y11.68% ROA5.90% Target Price46.73 Perf Year-21.36%
Cash/sh2.69 P/C14.12 EPS next 5Y9.40% ROE11.40% 52W Range35.78 - 50.81 Perf YTD-14.54%
Dividend1.04 P/FCF193.28 EPS past 5Y-10.30% ROI7.70% 52W High-25.39% Beta1.01
Dividend %2.74% Quick Ratio1.10 Sales past 5Y-10.30% Gross Margin56.90% 52W Low5.95% ATR0.67
Employees74000 Current Ratio1.50 Sales Q/Q-0.20% Oper. Margin13.60% RSI (14)41.07 Volatility1.69% 1.28%
OptionableYes Debt/Eq0.39 EPS Q/Q-89.20% Profit Margin12.00% Rel Volume1.71 Prev Close39.63
ShortableYes LT Debt/Eq0.29 EarningsJul 20 BMO Payout60.90% Avg Volume9.64M Price37.91
Recom2.00 SMA20-1.79% SMA50-3.97% SMA200-7.65% Volume16,516,381 Change-4.34%
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jan-30-15Reiterated Stifel Buy $47 → $49
Jan-30-15Reiterated Barclays Equal Weight $43 → $48
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jun-25-16 12:05PM  How Did Roches Diagnostics Division Perform?
Jun-24-16 10:38AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q1, 2016 By the Numbers : June 24, 2016
08:17AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : June 24, 2016
Jun-23-16 06:00AM  'Mad Money' Lightning Round: Intel Is Just Treading Water
Jun-22-16 11:34PM  Abbott Laboratories : ABT-US: Dividend Analysis : July 15th, 2016 : By the numbers : June 23, 2016
07:52PM  Cramer: Without business from Apple, it's treading water at CNBC
09:00AM  Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire
Jun-21-16 08:45PM  How Waltham's PerkinElmer became the world leader in newborn screening at bizjournals.com
09:18AM  Abbott Labs upgraded by Edward Jones
Jun-20-16 03:05PM  Epizyme Offers Early Data on Non-Hodgkin Lymphoma Drug
Jun-18-16 10:00PM  Opinions Differ on Abbott Deal to Acquire St. Jude's Medical
Jun-17-16 08:58AM  Abbott Laboratories (ABT) Is in Oversold Territory: What's Next?
12:23AM  Aegerion, QLT Ink Merger Deal to Form Novelion Therapeutics
Jun-16-16 01:08PM  Why M&A Deals Can Strengthen Moats
Jun-15-16 05:19PM  Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
Jun-14-16 06:18PM  Shire Gets Breakthrough Status for Rare Disease Candidates
03:28PM  Abbott Labs (ABT) Reports Positive Data on FreeStyle Libre
10:24AM  Abbott Laboratories (ABT) Stock Down, Jefferies Raises Price Target
Jun-13-16 09:00AM  Abbott Announces Positive Results from Groundbreaking Study of FreeStyle® Libre System for People with Type 1 Diabetes PR Newswire
08:01AM  Former Fed President: All My Very Rich Friends Are Holding a Lot of Cash
Jun-11-16 11:11AM  George Soros' Worst-Performing Stocks of 2016 So Far at Motley Fool
Jun-10-16 11:05AM  Abbott Declares 370th Consecutive Quarterly Dividend PR Newswire
Jun-09-16 09:50AM  7 Medical Stocks to Buy with Market-Beating Yields
Jun-08-16 11:24AM  Valeant (VRX) Stock Down on Bleak View, Q1 Earnings Miss
Jun-07-16 04:57PM  Merrimack Announces Positive Data on Oncology Candidate
03:46PM  Exelixis Up on Positive Kidney Cancer Data on Cabometyx
Jun-06-16 04:44PM  Novartis (NVS) Announces Data on Leukemia Drug Tasigna
Jun-02-16 05:00AM  No Easy Way Out for Abbott as Deal Target Faces Bribery Probe at Bloomberg
Jun-01-16 11:28AM  Abbott Says Its Auditing Alere Books; Got Partial Response at Bloomberg
May-31-16 04:15PM  Medtronics Initiative to Advance Type 2 Diabetes Device Business
01:36PM  Summer good for stocks?
09:35AM  This Health Care Dividend Aristocrat Will Profit From Old Age Globally at Insider Monkey
May-29-16 01:37PM  This Health Care Dividend Aristocrat Will Profit From Old Age a Globally
01:03PM  5 Trade Ideas for Tuesday: Abbott Labs, Alexion Pharma, Lear, M&T Bank and Panera
May-27-16 02:07PM  Medtronics Earnings Are Expected to See Growth in Fiscal 4Q16
11:42AM  3 Stand-Out Health Care Stocks for Dividends and Growth
May-26-16 12:01PM  Why Going Against the Herd to Buy Shares of Abbott Labs Is Smart
09:15AM  Morning Technical Review on Medical Appliances and Equipment Stocks
08:24AM  Short Interest In Abbott Labs And Baxter International Doubles
May-25-16 03:50PM  Novo Nordisk IDegLira Recommended by FDA Advisory Committee
11:26AM  Short Sellers Go to War Against 8 Well-Known Stocks in May at 24/7 Wall St.
May-20-16 11:10AM  Why Noble Energy, Grace, Boston Scientific Belong in Your Portfolio
07:08AM  These 3 Dividend Stocks Are Down Big -- but Do Their Charts Say Buy?
May-19-16 09:55AM  Should You Buy These 6 Oversold Stocks? The Charts Say No
May-18-16 09:28AM  3 Cheap Dividend Stocks Down Big That You Should Buy Now at TheStreet
May-17-16 11:30AM  The Secret To Getting 50% More Out Of Your Investments
May-16-16 02:23PM  6 Oversold Stocks That Aren't as Ugly as They Look at TheStreet
May-14-16 08:28AM  Citigroup (C) Supplanted Atop Diamond Hill Capitals Portfolio in Q1 at Insider Monkey
May-11-16 11:14AM  St. Jude Medical (STJ) Stock Up, Barclays: Abbott Deal Likely Closes in Q4 at TheStreet
07:00AM  Insulet Shares Swoon on Insurer Decision, but Fair Value Is Unchanged Morningstar
07:00AM  Insulet Shares Swoon on Insurer Decision, but Fair Value Is Unchanged at Morningstar
May-10-16 01:04PM  ABBOTT LABORATORIES Financials
12:41PM  New Curate Kids Combines Wholesome Ingredients and Kid-Friendly Flavors to Help Parents Win Snack-time PR Newswire
May-09-16 10:06PM  Will Professional Arbitrageurs Set Up the St. Jude-Abbott Merger? Market Realist
03:54PM  Why Alere Inc. Stock Plummeted 22.9% in April at Motley Fool
08:00AM  A Clever Way to Add Nutrition to Your Toddler's Favorite Foods: Go & Grow by Similac® Food Mix-Ins PR Newswire
May-08-16 03:30PM  Abbott Announces Positive Results from Pivotal Study of Tecnis® Symfony IOL for Cataract Surgery PR Newswire
May-06-16 09:07AM  Could the St. Jude Medical-Abbott Deal Get Competitive? Market Realist
May-05-16 05:13PM  Charts are bullish for health care: Technician Yahoo Finance
03:47PM  Why St. Jude Medical Inc. Stock Popped 38.1% in April at Motley Fool
12:07PM  Can the St. Jude Medical-Abbott Deal Get Antitrust Approval? Market Realist
10:08AM  What Are the Basics of the St. Jude Medical-Abbott Transaction? Market Realist
09:38AM  Abbott Laboratories (ABT) Is in Oversold Territory: What's Next? Zacks
May-04-16 05:32PM  ABBOTT LABORATORIES Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
04:48PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report EDGAR Online
04:00PM  Abbott to Present at Deutsche Bank Health Care Conference PR Newswire
09:08AM  Rationale for the St. Jude Medical-Abbott Merger Transaction Market Realist
09:00AM  America's Health Check-up: AARP and Abbott Survey Finds Half of Adults 50-Plus Wish They Had More Strength and Energy to Enjoy Daily Activities PR Newswire
08:53AM  Abbott Laboratories (ABT) Sees Hammer Chart Pattern: Time to Buy? Zacks
06:45AM  Abbott Buys St. Jude Medical for $85 per Share in Cash and Stock Market Realist
May-03-16 08:30PM  As Google's secretive biotech spinoff ramps up, look who it's hiring at American City Business Journals
May-02-16 04:17PM  Weekly Large-Cap Results: Boston Scientific Rose on 1Q16 Earnings Market Realist
02:26PM  This Undervalued Big Pharma Stock Hit Bottom and Is Ready to Break Out at TheStreet
01:59PM  ST. JUDE MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of St. Jude Medical, Inc. PR Newswire
01:29PM  IHIs Large-Caps: Abbott to Acquire St. Jude Medical Market Realist
11:15AM  Did Edwards Lifesciences 1Q16 Results Beat Expectations? Market Realist
Apr-30-16 12:01AM  [$$] Charting the Market at Barrons.com
Apr-29-16 08:33PM  [$$] Business Watch at The Wall Street Journal
05:22PM  Worst may be over for embattled pharma Yahoo Finance Contributors
04:14PM  $45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There Benzinga
03:45PM  Abbott Labs (ABT) Stock Plunges, Needham Downgrades on St. Jude Acquisition Concerns at TheStreet
02:14PM  Analysts Split On Abbott Lab's Purchase Of St. Jude at Barrons.com
01:54PM  Alere (ALR) Stock Plummets, Rejects Abbott's Request to End Merger at TheStreet
12:32PM  Pharma stocks to bet on CNBC
12:10PM  Valeant May Be Tip of Accounting Iceberg at Bloomberg
11:12AM  Correction: Abbott-St Jude Acquisition story AP
09:42AM  Faber Report: Abbott Labs CEO says Alere 'working through... CNBC
09:20AM  Abbott to Buy St. Jude Medical for $25 Billion at Investopedia
08:10AM  Abbott Laboratories breached its 50 day moving average in a Bearish Manner : ABT-US : April 29, 2016 at Capital Cube
08:01AM  The C-Suite Speaks: Looking for a Curveball Yahoo Finance Contributors
12:38AM  [$$] Abbott Agrees to Buy St. Jude in $25 Billion Deal at The Wall Street Journal
Apr-28-16 07:13PM  [$$] Abbott Agrees to Buy St. Jude in $25 Billion Deal at The Wall Street Journal -7.78%
07:02PM  Cramer: Worst May Be Over for Embattled Pharma at TheStreet
05:56PM  Why Textura, St. Jude Medical, and Cliffs Natural Resources Jumped Today at Motley Fool
05:01PM  US stocks skid as Apple pulls tech companies lower AP
04:52PM  [$$] Xilinx slides on downbeat sales outlook at Financial Times
04:43PM  US STOCKS-Wall St sinks on BOJ fears, Icahn comments Reuters
04:41PM  LPC: Abbotts $17.2 billion loan backing St. Jude acquisition set to boost M&A volume Reuters
04:40PM  Stocks End Sharply Lower; Amazon Surges Late On Earnings at Investor's Business Daily
04:37PM  Abbott deal for St. Jude spurs company split talk Reuters
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Mnire's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company's Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company has strategic alliance with Fonterra. Abbott Laboratories was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSenior Vice PresidentJun 15Sale37.6355220,77046,562Jun 17 05:05 PM
YOOR BRIAN BSenior Vice President and CFOJun 01Sale39.4956522,31249,617Jun 03 05:10 PM
NATH DEEPAK S.Senior Vice PresidentApr 28Sale41.31532,18947,382Apr 29 05:01 PM
Contreras JaimeSenior Vice PresidentMar 31Sale41.7846219,3042,426Apr 01 05:01 PM
Ford Robert BExecutive Vice PresidentFeb 29Sale39.281,70667,02060,789Mar 02 07:32 PM
NATH DEEPAK S.Senior Vice PresidentFeb 29Sale39.2779331,14247,571Mar 02 07:30 PM
Fussell Stephen RExecutive Vice PresidentFeb 29Sale39.261,40255,044154,967Mar 02 07:28 PM
Contreras JaimeSenior Vice PresidentFeb 29Sale38.9410,617413,40947,667Mar 02 07:28 PM
Blaser Brian JExecutive Vice PresidentFeb 29Sale39.291,54360,626129,482Mar 02 07:12 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 29Sale39.291,54360,61888,457Mar 02 07:11 PM
ASHLEY RICHARD WExecutive Vice PresidentFeb 29Sale39.283,086121,221354,517Mar 02 07:10 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentFeb 29Sale39.2688134,58961,792Mar 02 07:02 PM
YOOR BRIAN BSenior Vice President and CFOFeb 29Sale39.1286533,84351,385Mar 02 07:01 PM
Mason Heather LExecutive Vice PresidentFeb 29Sale39.273,032119,05565,102Mar 02 06:49 PM
Funck Robert EVice President, ControllerFeb 29Sale39.301,33352,39385,019Mar 02 06:07 PM
Warmuth Michael JExecutive Vice PresidentFeb 29Sale38.849,399365,09355,011Mar 02 05:14 PM
Pavee Jean-YvesSenior Vice PresidentFeb 29Sale39.241,66565,32636,149Mar 02 05:09 PM
NATH DEEPAK S.Senior Vice PresidentFeb 22Sale39.0931912,47150,404Feb 23 05:44 PM
Watkin JaredSenior Vice PresidentFeb 22Sale39.0955421,65848,535Feb 23 05:38 PM
NATH DEEPAK S.Senior Vice PresidentFeb 16Sale37.131716,34934,941Feb 17 05:57 PM
WHITE MILES DChairman and CEODec 16Option Exercise21.22438,0009,294,0971,832,153Dec 18 05:01 PM
WHITE MILES DChairman and CEODec 16Sale46.00438,00020,149,9581,394,153Dec 18 05:01 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 28Sale39.6581532,31239,974Sep 29 05:36 PM
Fussell Stephen RExecutive Vice PresidentAug 18Sale50.4613,096660,854130,601Aug 20 05:18 PM
Fussell Stephen RExecutive Vice PresidentAug 11Option Exercise21.2241,500880,605172,101Aug 13 05:02 PM
Funck Robert EVice President, ControllerJul 29Option Exercise21.2226,000551,70497,448Jul 30 05:51 PM
Blaser Brian JExecutive Vice PresidentJul 28Sale50.9611,300575,904102,194Jul 30 05:52 PM